RAPT Competitors & Alternatives

Compare RAPT Therapeutics Inc with similar stocks in the same industry

Biotechnology

RAPT

Main Stock
$58.02
+0.07%
Tradestie Score
50
Market Cap
$450.49M
Revenue Growth
-100.0%
Analyst Upside
0.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Small Molecule Drug Discovery
Competitive Moat: None
Core Technology Stack: CCR4 antagonist small molecules, oral immunology drugs
Major Customers 2
Clinical research organizations Academic collaborators
Critical Suppliers 2
CROs CMOs for API synthesis
Direct Ecosystem Rivals 3

Top Competitors

216 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ABCL AbCellera Biologics Inc. Common Shares
$11.14
-3.08%
$1.78B - 62 Compare
DYN Dyne Therapeutics, Inc. Common Stock
$16.70
-2.71%
$1.78B - 51 Compare
TWST Twist Bioscience Corporation Common Stock
$105.61
-5.37%
$1.77B - 52 Compare
VRDN Viridian Therapeutics, Inc. Common Stock
$30.37
-1.64%
$1.74B - 37 Compare
CLDX Celldex Therapeutics, Inc
$28.72
-0.40%
$1.68B - 55 Compare
MNKD Mannkind Corporation
$3.95
-4.48%
$1.65B - 36 Compare
EWTX Edgewise Therapeutics, Inc. Common Stock
$44.16
-3.85%
$1.63B 5.5 34 Compare
BHVN Biohaven Ltd.
$13.95
+0.90%
$1.57B - 42 Compare
VCEL Vericel Corporation
$57.68
+1.26%
$1.56B 90.3 35 Compare
DNTH Dianthus Therapeutics, Inc. Common Stock
$88.76
-3.33%
$1.55B - 32 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

216 stocks in this industry